Vivi Boura
Vivi Boura is a physician-trained scientist specializing in pulmonology and thoracic oncology. She earned her M.D. from the Aristotle University of Thessaloniki, School of Medicine, and a Ph.D. in medicine from the University of Athens, where her research focused on biomarkers in lung cancer. She began her academic and clinical career at the University of Athens, serving as Senior Research Associate in the 3rd Department of Internal Medicine, Oncology Unit. During this time, she contributed to more than 70 Phase 2/3 oncology clinical trials, including multinational and investigator-initiated studies. In parallel, she held academic roles, teaching at the University of Athens and lecturing in postgraduate programs on thoracic malignancies.
In 2021, Vivi joined SOTIO in Switzerland as Medical Director. She advanced through senior clinical development roles before being appointed Deputy Chief Medical Officer, where she led pre-IND and IND submissions in the field of antibody-drug conjugates (ADCs) and provided scientific and regulatory leadership in immunotherapies and ADC development.
Vivi has authored more than 40 peer-reviewed publications. In 2025, she was promoted to Chief Medical Officer.
SOTIO Biotech B.V.
Zuidplein 168
1077 XV Amsterdam
Netherlands
Zuidplein 168
1077 XV Amsterdam
Netherlands
SOTIO Biotech a.s.
Českomoravská 2532/19b
190 00 Prague 9
Czech Republic
Českomoravská 2532/19b
190 00 Prague 9
Czech Republic
SOTIO Biotech AG
Lichtstrasse 35 - WSJ-210
4056 Basel
Switzerland
Lichtstrasse 35 - WSJ-210
4056 Basel
Switzerland
SOTIO Biotech Inc.
180 Canal St., Suite 300
Boston, MA 02114
USA
180 Canal St., Suite 300
Boston, MA 02114
USA
